125 related articles for article (PubMed ID: 6682305)
1. The effect of prostaglandin E1 in patients undergoing clinical cardiopulmonary bypass.
van den Dungen JJ; Karliczek GF; Brenken U; van der Heide JN; Wildevuur CR
Ann Thorac Surg; 1983 Apr; 35(4):406-14. PubMed ID: 6682305
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic side effects of prostaglandin E1 in patients before and during cardiopulmonary bypass.
Karliczek G; van den Dungen JJ; Brenken U; Eijsman L; Kootstra GJ; Homan van der Heide JN; Wildevuur CR
Thorac Cardiovasc Surg; 1981 Feb; 29(1):55-9. PubMed ID: 6164120
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of prostaglandin E1 during cardiopulmonary bypass in infants and children.
Kawamura M; Minamikawa O; Yokochi H; Maki S; Yasuda T; Mizukawa Y
Jpn J Surg; 1982; 12(1):19-25. PubMed ID: 7200161
[TBL] [Abstract][Full Text] [Related]
4. Effects and arterial concentration of prostaglandin E1 during cardiopulmonary bypass.
Okuda M; Faruhashi K; Konishi K; Muneyuki M
Eur J Anaesthesiol; 1991 Mar; 8(2):129-34. PubMed ID: 1874208
[TBL] [Abstract][Full Text] [Related]
5. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
[No Abstract] [Full Text] [Related]
6. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
7. Increased anticoagulation during cardiopulmonary bypass by prostaglandin E1.
Kozek-Langenecker SA; Wanzel O; Berger R; Kettner SC; Coraim F
Anesth Analg; 1998 Nov; 87(5):985-8. PubMed ID: 9806669
[TBL] [Abstract][Full Text] [Related]
8. Effect of prostaglandin E1 in collagen disease patients with inflammatory skin ulcer.
Tohjima T; Shiokawa Y
Int J Tissue React; 1983; 5(1):1-10. PubMed ID: 6683263
[TBL] [Abstract][Full Text] [Related]
9. [Effects of prostaglandin E1 infusion during cardiopulmonary bypass].
Okuda M; Ohi Y; Utsunomiya H; Kurata M; Konishi K; Muneyuki M
Masui; 1989 Aug; 38(8):1036-41. PubMed ID: 2810697
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of prostaglandin E1 infusion in patients with acute myocardial infarction and left ventricular failure.
Popat KD; Pitt B
Am Heart J; 1982 Apr; 103(4 Pt 1):485-9. PubMed ID: 7199815
[TBL] [Abstract][Full Text] [Related]
11. [Platelet aggregation during hypotensive anesthesia using prostaglandin E1].
Tanaka M; Hosokawa T; Tanaka Y; Miyazaki M
Masui; 1991 Nov; 40(11):1636-40. PubMed ID: 1766114
[TBL] [Abstract][Full Text] [Related]
12. Depressed pulmonary removal of [3H]prostaglandin E1 after prolonged cardiopulmonary bypass.
Pitt BR; Hammond GL; Gillis CN
J Appl Physiol Respir Environ Exerc Physiol; 1982 Apr; 52(4):887-92. PubMed ID: 7200970
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
Khanna V; Armstrong PC; Warner TD; Curzen N
Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
[TBL] [Abstract][Full Text] [Related]
14. Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation.
Katzenschlager R; Weiss K; Rogatti W; Peskar BA; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 1992 Mar; 45(3):207-10. PubMed ID: 1589447
[TBL] [Abstract][Full Text] [Related]
15. The intrainfusion platelet rebound during and following PGE1-infusion is faster and more intensive than that with PGI2.
Sinzinger H; Reiter S
Prostaglandins Leukot Med; 1984 Mar; 13(3):281-8. PubMed ID: 6585847
[TBL] [Abstract][Full Text] [Related]
16. Evidence that intraoperative prostaglandin E1 infusion reduces impaired platelet aggregation after reperfusion in orthotopic liver transplantation.
Himmelreich G; Hundt K; Neuhaus P; Bechstein WO; Roissant R; Riess H
Transplantation; 1993 Apr; 55(4):819-26. PubMed ID: 8475558
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
[TBL] [Abstract][Full Text] [Related]
18. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass.
Boldt J; Knothe C; Zickmann B; Andres P; Dapper F; Hempelmann G
Anesth Analg; 1993 Jun; 76(6):1185-90. PubMed ID: 7684579
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805
[TBL] [Abstract][Full Text] [Related]
20. [Effects of prostaglandin E1 and dibutyryl cyclic AMP on hemodynamics after cardiopulmonary bypass in valve replacement surgery].
Sumiyoshi N; Kawachi S; Oishi K; Tsushima K; Nakatani T; Imanishi T; Matsuda M; Hirose T; Tagami D
Masui; 1992 Apr; 41(4):532-8. PubMed ID: 1315879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
